{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:46:30Z","timestamp":1771872390986,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.clindermatol.2003.11.013","type":"journal-article","created":{"date-parts":[[2004,5,29]],"date-time":"2004-05-29T13:36:16Z","timestamp":1085837776000},"page":"89-93","source":"Crossref","is-referenced-by-count":22,"title":["Botox: beyond wrinkles"],"prefix":"10.1016","volume":"22","author":[{"given":"Jean","family":"Carruthers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair","family":"Carruthers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2003.11.013_BIB1","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery","volume":"87","author":"Scott","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB2","first-page":"135","article-title":"Ophthalmologic use of botulinum A exotoxin","volume":"20","author":"Carruthers","year":"1985","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB3","first-page":"212","article-title":"Injection of type A botulinum toxin into extraocular muscles for correction of strabismus","volume":"22","author":"Flanders","year":"1987","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1034\/j.1600-0420.1998.760106.x","article-title":"Treatment of strabismus and nystagmus with botulinum toxin type A","volume":"76","author":"Lennerstrand","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0161-6420(91)32264-4","article-title":"Use of botulinum toxin in strabismus after retinal detachment surgery","volume":"98","author":"Petitto","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0161-6420(89)32777-1","article-title":"Chemodenervation of strabismic children","volume":"96","author":"Magoon","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB7","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0161-6420(90)32390-4","article-title":"Botulinum treatment of childhood strabismus","volume":"97","author":"Scott","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB8","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0161-6420(89)32776-X","article-title":"Management of strabismus with botulinum A toxin","volume":"96","author":"Biglan","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/bjo.83.7.783","article-title":"Early retreatment of infantile esotropia","volume":"83","author":"Tejedor","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB10","first-page":"1189","article-title":"Botulinum A toxin therapy on esotropia in children","volume":"85","author":"Tengtrisorn","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB11","first-page":"9","article-title":"Botulinum toxin as a treatment for strabismus in systemic diseases","volume":"78","author":"Moguel-Ancheita","year":"2003","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"suppl","key":"10.1016\/j.clindermatol.2003.11.013_BIB12","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1097\/00002508-200211001-00005","article-title":"Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction","volume":"18","author":"Lew","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB13","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archopht.1984.01040031184014","article-title":"Treatment of blepharospasm with botulinum toxin","volume":"102","author":"Frueh","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archopht.1985.01050030043017","article-title":"Botulinum A toxin injection as a treatment for blepharospasm","volume":"103","author":"Scott","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB15","doi-asserted-by":"crossref","unstructured":"Carruthers JDA, Stubbs HA. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age related lower eyelid entropion. The Canadian Journal of Neurological Sciences. Vol. 14 No. 1, 42\u221245, Feb 1987.","DOI":"10.1017\/S0317167100026159"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0002-9394(85)90228-4","article-title":"Treatment of blepharospasm with botulinum toxin","volume":"99","author":"Tsoy","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archneur.1986.00520040060020","article-title":"Botulinum toxin in the management of blepharospasm","volume":"43","author":"Dutton","year":"1986","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB18","series-title":"Therapy with botulinum toxin","first-page":"199","article-title":"Acute and chronic effects of botulinum toxin in the management of blepharospasm","author":"Dutton","year":"1994"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1017\/S0317167100026159","article-title":"Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion","volume":"14","author":"Carruthers","year":"1987","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB20","first-page":"1","article-title":"Botulinum A toxin treatment for blepharospasm and Meige syndrome","volume":"80","author":"Poungvarin","year":"1997","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB21","first-page":"326","article-title":"A five-year analysis of botulinum toxin type A injections","volume":"23","author":"Balkan","year":"1991","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB22","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1740::AID-MUS17>3.0.CO;2-V","article-title":"Hemifacial spasm","volume":"21","author":"Wang","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1212\/WNL.43.4.834","article-title":"Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia","volume":"43","author":"Jankovic","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0161-6420(97)30220-6","article-title":"Blepharospasm and hemifacial spasm. randomized trial to determine the most appropriate location for botulinum toxin injections","volume":"104","author":"Price","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB25","unstructured":"Stacy MS. Efficacy of botulinum toxin type B (Myobloc; Nuerobloc) for treatment of blepharospasm: report of two cases. Presented at the International Conference, June 8-11, 2002. Hannover, Germany"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB26","unstructured":"WE MOVE. Practical considerations for the clinical use of botulinum toxin type B: A self-study continuing medical education activity. February, 2002"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB27","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/mds.10252","article-title":"Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period","volume":"17","author":"Hsiung","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/qjmed\/95.8.493","article-title":"Hemifacial spasm and involuntary facial movements","volume":"95","author":"Tan","year":"2002","journal-title":"Q J Med"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB29","unstructured":"Hobson DE. Botulinum Toxin: a review of its therapeutic role in movement disorders. Botulium Toxin. The Canadian Movement Disorder Group, 2001. Accessible at: http:\/\/www.cmdg.org\/medicati\/botox\/botox.htm"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB30","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1212\/WNL.45.9.1743","article-title":"Response and immunoresistance to botulinum toxin injections","volume":"45","author":"Jankovic","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.46.1.26","article-title":"Botulinum toxin therapy, immunologic resistance, and problems with available materials","volume":"46","author":"Borodic","year":"1996","journal-title":"Neurology"},{"issue":"pt 1","key":"10.1016\/j.clindermatol.2003.11.013_BIB32","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1212\/WNL.45.3.506","article-title":"Comparison of therapeutic efficacies of type A and F botulinum toxins for blepharospasm","volume":"45","author":"Mezaki","year":"1995","journal-title":"Neurology"},{"issue":"suppl","key":"10.1016\/j.clindermatol.2003.11.013_BIB33","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0022-510X(97)85177-5","article-title":"Botulinum toxin for axillary and palmar hyperhidrosis","volume":"150","author":"Bushara","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB34","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1076-0512(98)00077-6","article-title":"Botulinum A neurotoxin for axillary hyperhidrosis","volume":"24","author":"Glogau","year":"1998","journal-title":"Dermatol Surg"},{"issue":"suppl 4","key":"10.1016\/j.clindermatol.2003.11.013_BIB35","first-page":"S117","article-title":"Treatment of focal hyperhidrosis with botulinum toxin type A","volume":"6","author":"Naver","year":"1996","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0149-2918(03)90041-5","article-title":"Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin","volume":"25","author":"Campanati","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archderm.139.1.57","article-title":"Amelioration of body odor after intracutaneous axillary injection of botulinum toxin A","volume":"139","author":"Heckmann","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB38","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/bmj.323.7313.596","article-title":"Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis","volume":"323","author":"Naumann","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1524-4725.2003.29128.x","article-title":"Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis","volume":"29","author":"Lowe","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/archderm.139.6.731","article-title":"Botulinum toxin type A is a safe and effective treatment for axillary hyperhidrosis over 16 months","volume":"139","author":"Naumann","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1524-4725.2003.29129.x","article-title":"Complications, adverse reactions, and insights with the use of botulinum toxin","volume":"29","author":"Klein","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB42","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1046\/j.1524-4725.2002.02039.x","article-title":"Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis","volume":"28","author":"Lowe","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB43","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1524-4725.2003.29126.x","article-title":"Diffusion and short-term efficacy of botulinum toxin A after the addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis","volume":"29","author":"Goodman","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB44","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00415-002-0929-4","article-title":"Botulinum toxin type B for treatment of axillary hyperhidrosis","volume":"249","author":"Dressler","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB45","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2165\/00003495-200161130-00004","article-title":"Cervical dystonia","volume":"61","author":"Velickovic","year":"2001","journal-title":"Drugs"},{"issue":"suppl","key":"10.1016\/j.clindermatol.2003.11.013_BIB46","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1097\/00002508-200211001-00010","article-title":"A focused review on the use of botulinum toxins for neuropathic pain","volume":"18","author":"Argoff","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/mda.2002.24423","article-title":"Botulinum toxin type A (BOTOX) for treatment of migraine","volume":"48","author":"Binder","year":"2002","journal-title":"Dis Mon"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB48","doi-asserted-by":"crossref","unstructured":"Klein AW, Glogau RG. Botulinum toxin: beyond cosmesis. Arch Dermatol 2000 Apr;136(4):539\u221241","DOI":"10.1001\/archderm.136.4.539"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB49","unstructured":"Barrientos N, Chana P. Efficacy and safety of botulinum toxin type A (BOTOX) in the prophylactic treatment of migraine. Presented at the American Headache Society 44th Annual Scientific Meeting. June 21-23, 2002. Seattle, Washington"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB50","unstructured":"Mauskop A. Long-term use of botulinum toxine type A (BOTOX) in the treatment of episodic and chronic migraine headaches. Presented at the American Headache Society 44th Annual Scientific Meeting. June 21-23, 2002. Seattle, Washington"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB51","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1067\/mhn.2000.110960","article-title":"Botulinum toxin type A (BOTOX) for treatment of migraine headaches","volume":"123","author":"Binder","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1526-4610.2000.00066.x","article-title":"Botulinum toxin type A as a migraine preventive treatment","volume":"40","author":"Silberstein","year":"2000","journal-title":"Headache"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB53","unstructured":"Mathew NT, Kallasam J, Kaupp A, et al. \u2018Disease modification\u2019 in chronic migraine with botulinum toxin type A: long-term experience. Presented at the American Headache Society 44th Annual Scientific Meeting. June 21-23, 2002. Seattle, Washington. Abstract"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB54","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1526-4610.1999.3909662.x","article-title":"Improvement for tension-type headache when treating wrinkles with botulinum toxin-A injections","volume":"39","author":"Carruthers","year":"1999","journal-title":"J Head Face Pain"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB55","first-page":"433","article-title":"A focal dystonia model for subsets of chronic tension headache","volume":"20","author":"Freund","year":"2000","journal-title":"Cephalalgia"},{"issue":"suppl 4","key":"10.1016\/j.clindermatol.2003.11.013_BIB56","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1111\/j.1468-1331.1999.tb00044.x","article-title":"Prophylactic treatment of chronic tension-type headache using botulinum toxin type A","volume":"6","author":"Smuts","year":"1999","journal-title":"Eur J Neurol"},{"issue":"suppl 2","key":"10.1016\/j.clindermatol.2003.11.013_BIB57","first-page":"S71","article-title":"Treatment of tension-type headache by local injection of botulinum toxin","volume":"4","author":"Relja","year":"1997","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB58","first-page":"183","article-title":"Treatment of tension-type headache with botulinum toxin","volume":"4","author":"Schulte-Mattler","year":"1999","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB59","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1526-4610.1994.hed3408458.x","article-title":"Tension headache","volume":"34","author":"Zwart","year":"1994","journal-title":"Headache"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB60","first-page":"455","article-title":"Treatment of chronic tension-type headache with botulinum toxin","volume":"19","author":"G\u00f6bel","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB61","doi-asserted-by":"crossref","unstructured":"Blumenfeld A. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders. Headache 2003;43:853-60","DOI":"10.1046\/j.1526-4610.2003.03163.x"},{"issue":"suppl","key":"10.1016\/j.clindermatol.2003.11.013_BIB62","first-page":"10","article-title":"Open-label study of Myobloc (botulinum toxin type B) in the treatment of patients with transformed migraine headaches","volume":"3","author":"Opida","year":"2002","journal-title":"J Pain"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB63","unstructured":"Freund B, Schwartz M. ubcutaneous BTX-A in the treatment of neuropathic pain: a pilot study. Presented at the 38th Interagency Botulism Research Coordinating Committee Meeting. October 17-19, 2001. Easton, Maryland"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB64","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00002826-200209000-00006","article-title":"Beneficial effects of botulinum toxin type A for patients with painful tic convulsive","volume":"25","author":"Micheli","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB65","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1442-2050.2003.00287.x","article-title":"Intrasphincteric botulinum toxin injection in the treatment of chagasic achalasia","volume":"16","author":"Brant","year":"2003","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB66","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1468-3083.2002.00490.x","article-title":"Botulinum toxin A in anal fissures","volume":"16","author":"Wollina","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB67","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2036.1995.tb00428.x","article-title":"Review article","volume":"9","author":"Albanese","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clindermatol.2003.11.013_BIB68","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1046\/j.1365-2036.2000.00765.x","article-title":"Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats","volume":"14","author":"Gui","year":"2000","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X03001159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X03001159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T12:21:35Z","timestamp":1549542095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X03001159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0738081X03001159"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2003.11.013","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}